000 01487 a2200397 4500
005 20250513030016.0
264 0 _c19951205
008 199512s 0 0 eng d
022 _a0004-0010
024 7 _a10.1001/archsurg.1995.01430110075014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aConti, D J
245 0 0 _aPreemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients.
_h[electronic resource]
260 _bArchives of surgery (Chicago, Ill. : 1960)
_cNov 1995
300 _a1217-21; discussion 1221-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntibodies, Viral
_xblood
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCytomegalovirus
_ximmunology
650 0 4 _aCytomegalovirus Infections
_xepidemiology
650 0 4 _aFemale
650 0 4 _aGanciclovir
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aKidney Transplantation
_xadverse effects
650 0 4 _aMale
650 0 4 _aProspective Studies
700 1 _aFreed, B M
700 1 _aSingh, T P
700 1 _aGallichio, M
700 1 _aGruber, S A
700 1 _aLempert, N
773 0 _tArchives of surgery (Chicago, Ill. : 1960)
_gvol. 130
_gno. 11
_gp. 1217-21; discussion 1221-2
856 4 0 _uhttps://doi.org/10.1001/archsurg.1995.01430110075014
_zAvailable from publisher's website
999 _c7486935
_d7486935